T 1196/21 (Therapeutic uses of Prevotella strains/PROPREV) of 15.05.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T119621.20230515
- Date of decision
- 15 May 2023
- Case number
- T 1196/21
- Online on
- 16 June 2023
- Petition for review of
- -
- Application number
- 14808269.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA
- Applicant name
- Proprev AB
- Opponent name
- DuPont Nutrition Biosciences ApS
- Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Main request: sufficiency of disclosure - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is maintained as granted.